| Grant Title | Grantor | Amount | Award Date |
|---|
| Daryl Okamura, MD | Uncovering CD36-mediated oxidative and inflammatory pathways in progressive renal fibrosis | unknown |
$50,000.00 | April 1, 2009 |
| Bruder Stapleton, MD | Cancer Center Support | FHCRC-NIH |
$299,556 | Jan. 1, 2009 - Dec. 31, 2014 |
| Daryl Okamura, MD | Cysteamine effects on extracellular matrix accumulation in chronic kidney disease | Cystinosis Research Foundation Award |
$89,069.00 | July 1, 2008 |
| Bruder Stapleton, MD | Cell and Molecular Biology of Development | National Institutes of Health |
$2,000,000 | Nov. 30, 2007 - Nov. 30, 2012 |
| Daryl Okamura, MD | Role of CD36 in oxidative and inflammatory pathways in renal fibrosis | National Kidney Foundation |
$50,000.00 | July 1, 2007 |
| Daryl Okamura, MD | Multifunctional role of CD36 in progressive renal fibrosis | unknown |
$128,250.00 | July 1, 2006 |
| Daryl Okamura, MD | Multifunctional role of CD36 in progressive renal fibrosis | NIH |
$35,000.00 | July 1, 2004 |
| Bruder Stapleton, MD | Cancer Center Support | FHCRC-NIH |
$299,556 | Jan. 1, 2003 - Dec. 31, 2008 |
| Bruder Stapleton, MD | Cell and Molecular Biology of Development | National Institutes of Health |
$2,000,000 | Nov. 30, 2002 - Nov. 30, 2007 |
| Bruder Stapleton, MD | International Pediatric Nephrology Conference | National Insitutes of Health |
$23,000 | Jan. 1, 2001 - Dec. 31, 2001 |
| Bruder Stapleton, MD | Cell and Molecular Biology of Development | National Institutes of Health |
$232,163 | Dec. 1, 1997 - Nov. 30, 2002 |
| Bruder Stapleton, MD | Cell and Molecular Biology of Development | National Institutes of Health |
$177,471 | Jan. 15, 1996 - Aug. 31, 1997 |
| Bruder Stapleton, MD | New York State Department of Health, AIDS Institute: Women's and Children's Initiative | SUNYAB Departments of OB/GYN and Pediatrics in collaboration with the Erie County Medical Center. |
$195,000 | July 1, 1995 - July 1, 1996 |
| Bruder Stapleton, MD | Immunization Education Grant | New York State Department of Health |
$150,000 | 1995 - 1996 |
| Bruder Stapleton, MD | Short-Term Training of Minority Medical Students | National Institutes of Health |
$271,365 | Sept. 30, 1992 - Sept. 29, 1997 |
| Bruder Stapleton, MD | Community Academic Practice Site Development Program | Indirect Medical Education Demonstration Project Grants |
$315,100 | Sept. 1, 1992 - Aug. 31, 1994 |
| Bruder Stapleton, MD | Primary Care Resident Recruitment Program | Indirect Medical Education Demonstration Project Grants |
$389,057 | Sept. 1, 1992 - Aug. 31, 1994 |
| Bruder Stapleton, MD | Comprehensive Minority Recruitment Project | Indirect Medical Education Demonstration Project Grants |
$259,400 | Sept. 1, 1992 - Aug. 31, 1994 |
| Bruder Stapleton, MD | Calcium Control of PTH Secretion | General Clinical Research Center-Clinical Associate Physician |
$176,376 | April 1, 1988 - March 31, 1991 |
| Bruder Stapleton, MD | Potassium Citrate Therapy in Children with Hypercalciuria and/or Hypocitraturia | LeBonheur Children's Medical Center Research Fund |
$6258 | 1988 |
| Bruder Stapleton, MD | Competitive Renewal | General Clinical Research Center |
$11,108,911 | 1988 - 1993 |
| Bruder Stapleton, MD | North American Pediatric Renal Transplant Cooperative Study | | | 1987 |
| Bruder Stapleton, MD | Risk of Renal Calcifications in Children with Hypercalciuria | LeBonheur Children's Medical Center Research Fund |
$5000 | 1987 |
| Bruder Stapleton, MD | Diagnostic Studies on the Pathogenesis of Hematuria in Children with Hypercalciuria | LeBonheur Children's Medical Center Research Fund |
$4900 | 1986 |
| Bruder Stapleton, MD | Diet Protein, Growth, GFR in Infants with Renal Failure | National Institutes of Health |
$2,121,931 | Dec. 1, 1985 - Nov. 30, 1990 |
| Bruder Stapleton, MD | Cardiovascular Reactivity in Children of Adults with Essential Hypertension | National Institutes of Health |
$574,937 | Sept. 29, 1985 - Sept. 29, 1989 |
| Bruder Stapleton, MD | Clinical Reseach | Tennessee Higher Education Council, Centers for Excellence Application, Center for Pediatric Therapeutics and Pharmacokinetics |
$1,674,000 | July 1, 1985 - June 30, 1991 |
| Bruder Stapleton, MD | Oxypurine Excretion in Critically Ill Children | LeBonheur Children's Medical Center Research Fund |
$3000 | 1985 |
| Bruder Stapleton, MD | Renewal Grant | General Clinical Research Center |
$4,500,000 | 1985 - 1989 |
| Bruder Stapleton, MD | Efficacy of Live Attenuated VZ Vaccine in Children with Childhood Nephrotic Syndrome | Merck Sharp and Dohme |
$3000/year | Sept. 1985 |
| Bruder Stapleton, MD | Prognostic Significance of Serum and Urinary Uric Acid Concentration in Children Admitted to an Intensive Care Unit | LeBonheur Children's Medical Center Research Fund |
$2500 | 1984 |
| Bruder Stapleton, MD | Collaborative Studies of Pediatric Renal Diseases. | National Institutes of Health |
$606,843 | Sept. 30, 1983 - Aug. 31, 1988 |
| Bruder Stapleton, MD | Growth Failure in Children with Renal Diseases | National Institutes of Health |
$3,028,634 | April 1, 1983 - March 30, 1987 |
| Bruder Stapleton, MD | Hypercalciuria in Children | General Clinical Research Center Clinical Associate Physician |
$125,069 | July 1, 1982 - June 30, 1985 |
| Bruder Stapleton, MD | Uric Acid Excretion in Human and Canine Neonates | University of Tennessee Center for the Health Sciences, New Faculty Grant |
$38,676. | Jan. 1, 1980 - Dec. 31, 1981 |
| Bruder Stapleton, MD | Urinary Excretion of Calcium and Uric Acid in Healthy Children - Response to Calcium Loading | LeBonheur Children's Medical Center, Pediatric Urology and Nephrology Research Fund |
$1000 | |